Published in J Virol on April 01, 2002
Capped small RNAs and MOV10 in human hepatitis delta virus replication. Nat Struct Mol Biol (2008) 1.34
RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol (2005) 1.21
HDV-like self-cleaving ribozymes. RNA Biol (2011) 1.12
Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J Virol (2002) 1.10
Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol (2004) 1.08
Transcription of hepatitis delta virus RNA by RNA polymerase II. J Virol (2007) 1.05
Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established. J Virol (2002) 0.99
RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies. J Virol (2006) 0.97
Differential subnuclear localization of RNA strands of opposite polarity derived from an autonomously replicating viroid. Plant Cell (2003) 0.96
Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication. RNA (2009) 0.95
Modification of small hepatitis delta virus antigen by SUMO protein. J Virol (2009) 0.92
Features affecting the ability of hepatitis delta virus RNAs to initiate RNA-directed RNA synthesis. J Virol (2004) 0.92
Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs. RNA (2004) 0.91
Interaction of host cellular proteins with components of the hepatitis delta virus. Viruses (2010) 0.89
Determination of the multimerization state of the hepatitis delta virus antigens in vivo. J Virol (2003) 0.88
Alternative processing of hepatitis delta virus antigenomic RNA transcripts. J Virol (2004) 0.87
Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis. J Virol (2008) 0.87
Hepatitis delta antigen requires a minimum length of the hepatitis delta virus unbranched rod RNA structure for binding. J Virol (2009) 0.87
Formation of an RNA polymerase II preinitiation complex on an RNA promoter derived from the hepatitis delta virus RNA genome. Nucleic Acids Res (2008) 0.86
Action of inhibitors on accumulation of processed hepatitis delta virus RNAs. J Virol (2006) 0.85
Hepatitis delta virus RNA replication. Viruses (2009) 0.84
Hepatitis delta virus RNA encoding the large delta antigen cannot sustain replication due to rapid accumulation of mutations associated with RNA editing. J Virol (2003) 0.83
Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication. J Virol (2007) 0.83
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options. Nat Rev Gastroenterol Hepatol (2016) 0.82
Hepatitis delta virus: a peculiar virus. Adv Virol (2013) 0.82
RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells. J Virol (2005) 0.82
Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II. J Virol (2009) 0.81
The poly(A) site sequence in HDV RNA alters both extent and rate of self-cleavage of the antigenomic ribozyme. Nucleic Acids Res (2008) 0.78
Rolling circle replication requires single-stranded DNA binding protein to avoid termination and production of double-stranded DNA. Nucleic Acids Res (2014) 0.77
Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus. World J Gastroenterol (2014) 0.77
Hepatitis delta virus: A fascinating and neglected pathogen. World J Virol (2015) 0.75
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res (1982) 11.72
Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites. Cell (1987) 8.19
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
Crystal structure of a hepatitis delta virus ribozyme. Nature (1998) 7.07
Autolytic processing of dimeric plant virus satellite RNA. Science (1986) 6.14
Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 5.48
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
A replication cycle for viroids and other small infectious RNA's. Science (1984) 5.18
Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell (1979) 3.67
The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc Natl Acad Sci U S A (1991) 3.52
RNA catalytic properties of the minimum (-)sTRSV sequence. Biochemistry (1989) 3.07
The molecular biology of hepatitis delta virus. Annu Rev Biochem (1995) 2.92
Isolation of an RNA-directed RNA polymerase-specific cDNA clone from tomato. Plant Cell (1998) 2.17
Multiple transcript cleavage precedes polymerase release in termination by RNA polymerase II. Cell (2001) 2.15
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol (1991) 1.79
Hepatitis delta antigen is necessary for access of hepatitis delta virus RNA to the cell transcriptional machinery but is not part of the transcriptional complex. Virology (1991) 1.69
Stimulation of RNA polymerase II elongation by hepatitis delta antigen. Science (2001) 1.66
A revised replication cycle for viroids: the role of longer than unit length RNA in viroid replication. Mol Gen Genet (1984) 1.64
The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol (1993) 1.62
Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line. Virology (1990) 1.56
Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication. J Virol (1998) 1.51
RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol (2000) 1.36
Specific HDV RNA-templated transcription by pol II in vitro. RNA (2000) 1.36
Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol (1993) 1.34
A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication. J Virol (1996) 1.25
Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome. J Virol (2001) 1.21
Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. Virology (1988) 1.17
A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs. Proc Natl Acad Sci U S A (2000) 1.16
Regulation of the hepatitis delta virus ribozymes: to cleave or not to cleave? RNA (1995) 1.14
The nucleolin binding activity of hepatitis delta antigen is associated with nucleolus targeting. J Biol Chem (1998) 1.14
The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication. J Biol Chem (2001) 1.12
Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J Virol (2002) 1.10
Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol (1996) 1.09
The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J Virol (2000) 1.07
Identification and characterization of the RNA chaperone activity of hepatitis delta antigen peptides. J Biol Chem (1998) 1.05
Hepatitis delta virus: the molecular basis of laboratory diagnosis. Crit Rev Clin Lab Sci (2000) 0.97
Antisense globin RNA in mouse erythroid tissues: structure, origin, and possible function. Proc Natl Acad Sci U S A (1996) 0.97
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet (2011) 5.68
Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol (2004) 2.89
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol (2003) 2.86
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol (2003) 2.60
Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology (2002) 2.55
Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A (2004) 2.30
Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology (2004) 2.28
Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology (2003) 2.14
Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol (2005) 1.86
Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology (2004) 1.71
Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol (2008) 1.65
Palmitoylation and polymerization of hepatitis C virus NS4B protein. J Virol (2006) 1.59
Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A (2006) 1.59
Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52
Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol (2006) 1.44
Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J Virol (2008) 1.43
Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol (2005) 1.40
Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol (2006) 1.38
Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity. J Virol (2004) 1.37
Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase. J Virol (2003) 1.32
Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J (2010) 1.30
Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol (2004) 1.30
The hepatitis C virus persistence: how to evade the immune system? J Biosci (2003) 1.29
Rab5 and class III phosphoinositide 3-kinase Vps34 are involved in hepatitis C virus NS4B-induced autophagy. J Virol (2011) 1.27
High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc Natl Acad Sci U S A (2010) 1.24
Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J Virol (2002) 1.22
c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair. Hepatology (2010) 1.20
Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology (2002) 1.17
Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. Virology (2007) 1.16
Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. J Immunol (2010) 1.16
The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry. J Virol (2005) 1.15
Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology (2006) 1.14
Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J Virol (2002) 1.10
Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A. J Virol (2010) 1.09
Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol (2004) 1.08
Polypyrimidine-tract-binding protein affects transcription but not translation of mouse hepatitis virus RNA. Virology (2002) 1.08
Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. Biochemistry (2003) 1.06
Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis. J Biomed Sci (2006) 1.06
Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors. Antimicrob Agents Chemother (2008) 1.05
Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci U S A (2013) 1.04
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735. Mol Cancer Ther (2012) 1.04
Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein. J Virol (2008) 1.03
The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo. J Virol (2004) 1.03
Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines. Virology (2002) 1.01
Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation. J Biol Chem (2002) 1.00
Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase. Mol Cell Biol (2006) 1.00
Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter. Pharmacogenet Genomics (2007) 1.00
Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established. J Virol (2002) 0.99
Hepatitis C virus egress and release depend on endosomal trafficking of core protein. J Virol (2010) 0.98
Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft. J Virol (2012) 0.97
RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies. J Virol (2006) 0.97
SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis. J Virol (2004) 0.97
Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry. J Biol Chem (2012) 0.97
Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: function of the last 21 amino acids of the C terminus in template binding and RNA synthesis. Biochemistry (2004) 0.97
Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release. J Virol (2005) 0.96
Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein. J Virol (2009) 0.96
Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis. J Virol (2003) 0.96
Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. N Engl J Med (2003) 0.95
SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication. Virology (2009) 0.94
Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity. J Virol (2002) 0.94
Identification of RNA ligands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates. Virology (2003) 0.94
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871). Mol Cancer Ther (2013) 0.93
Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. J Infect Dis (2009) 0.92
Modification of small hepatitis delta virus antigen by SUMO protein. J Virol (2009) 0.92
Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J Virol (2009) 0.91
HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice. Hepatology (2006) 0.89
Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis. J Virol (2008) 0.87
Redox modulation of the hepatitis C virus replication complex is calcium dependent. Free Radic Biol Med (2006) 0.85
Hepatitis delta virus RNA replication. Viruses (2009) 0.84
Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges. Future Med Chem (2010) 0.84
Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2), a host membrane-deforming protein, is critical for membranous web formation in hepatitis C virus replication. J Virol (2011) 0.83
Hepatitis delta virus RNA encoding the large delta antigen cannot sustain replication due to rapid accumulation of mutations associated with RNA editing. J Virol (2003) 0.83
Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity. Virology (2004) 0.83
The 8ab protein of SARS-CoV is a luminal ER membrane-associated protein and induces the activation of ATF6. Virology (2009) 0.81
Attenuation of 40S ribosomal subunit abundance differentially affects host and HCV translation and suppresses HCV replication. PLoS Pathog (2012) 0.81
Hepatitis C virus translation preferentially depends on active RNA replication. PLoS One (2012) 0.80
Detection and characterization of small and large HDV antigens. Methods Mol Med (2004) 0.75
[Hepatitis C virus replication associated with lipid rafts]. Seikagaku (2006) 0.75
Hepatitis delta virus RNA transfection for the cell culture model. Methods Mol Med (2004) 0.75